World Hospital Infection Therapeutics Market Manufacturers, Regions, Types, Major Drivers, Revenue GlaxoSmithKline plc, AstraZeneca plc, Merck & Co., Inc., Pfizer, Inc, Actavis plc, Bayer AG, Johnson & Johnson, Bristol-Myers Squibb Company and Cubist Phar

Hospital acquired infections (HAIs) are one of the leading cause of death across the globe. They are also referred to as nosocomial infections or Healthcare-associated Infections. According to Centers for Disease Control and Prevention (CDC), 1 out of every 25 hospital admitted patient gets contracted with HAIs. Moreover, in the U.S., in 2011, around 75,000 hospitalized patients died from HAIs. The global hospital acquired therapeutics market has observed a significant growth owing to rising number of hospital admitted patients and improved diagnostics capable of differentiating different strains of microbes.

Complacency among healthcare providers and poor maintenance of hygiene are the two major preventable causes leading to HAIs. The global market is facing significant challenges such as growing antimicrobial resistance among certain strains of bacteria eg. Methicillin-Resistant Staphylococcus Aureus (MRSA). The major drivers of global hospital infection therapeutics market are the rising number of hospital admitted patients, poor infrastructure, understaffing and insufficient hospital equipment, overcrowding and lack of knowledge about blood transfusion safety measures, and rising geriatric population.

Sample Report @
https://www.alliedmarketresearch.com/request-toc-and-sample/1496

The global hospital infection therapeutics market is segmented on the basis of drug type, application, and geography. On the basis of drug type, the market is segmented into Antibiotics Drugs, Antifungal Drugs, Antiviral Drugs and Others. According to application, the global market is segmented into, Bloodstream Infections, Pneumonia, Surgical Site Infections, Urinary Tract Infections, Gastrointestinal Disorders and Other Hospital Infections.

Top key players :

• Sanofi S.A.
• GlaxoSmithKline plc
• AstraZeneca plc
• Merck & Co. Inc.
• Pfizer Inc
• Actavi s plc
• Bayer AG
• Johnson & Johnson
• Bristol-Myers Squibb Company
• Cubist Pharmaceuticals Inc.

Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific and LAMEA. New drug approval and acquisitions are key strategies adopted by the top industry players. For instance FDA approved a new drug named Oritavancin, an intravenous antibiotic, for the treatment of drug-resistant bacteria, including MRSA. Merck & Co. has acquired Cubist Pharmaceuticals, a company with late-stage pipeline focusing on healthcare-acquired bacterial infections.

Send Enquiry on this report @
https://www.alliedmarketresearch.com/purchase-enquiry/1496

KEY MARKET BENEFITS:

• Comprehensive analysis of factors that drive and restrict the growth of the global hospital infection therapeutics market is provided

• The report provides a comprehensive analysis of the current market and estimations through 20142020, which would enable the stakeholders to capitalize on prevailing market opportunities

• An in-depth analysis of key segments of the market demonstrate the types of drugs along with the applications in the hospital infection therapeutics market

• SWOT analysis enables to study the internal environment of the leading companies for strategy formulation

• Region-wise hospital infection therapeutics market scenario is comprehensively analyzed in the report

KEY MARKET SEGMENTS:

The global Hospital Infection Therapeutics market is segmented below:

Hospital Infection Therapeutics Market By Drug Type
• Antibiotics Drugs
• Antifungal Drugs
• Antiviral Drugs
• Others

Hospital Infection Therapeutics Market By Applications
• Bloodstream Infections
• Pneumonia
• Surgical Site Infections
• Urinary Tract Infections
• Gastrointestinal Disorders
• Other Hospital Infections

Get Access to Full summary of this report at :
https://www.alliedmarketresearch.com/hospital-infection-therapeutics-market

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Deep joshi
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.